Superworth

SS Innovations International profit margin SSII

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
−23.7%
Operating margin, 12 months
−16.2%
Net margin on a year earlier
+16.5 pts
Peer median
7.8%

Over the twelve months to Jun 30, 2026, SS Innovations International kept −23.7% of its revenue as net profit, with an operating margin of −16.2% and a gross margin of 47.6%.

The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−28.5%−19.8%46.0%
FY2024−92.7%−91.9%40.9%
FY2023n/an/a12.3%
FY2022n/an/an/a
FY2021n/an/an/a
FY2020n/an/an/a
FY2019n/an/an/a
FY2018n/an/an/a
FY2017n/an/an/a
FY2016n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−23.7%+16.5 pts−16.2%
Q1 FY26−20.7%+47.0 pts−12.6%
Q4 FY25−28.5%+64.2 pts−19.8%
Q3 FY25−32.1%n/a−26.3%
Q2 FY25−40.2%n/a−39.3%
Q1 FY25−67.7%n/a−68.1%
Q4 FY24−92.7%n/a−91.9%
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest SS Innovations International's size, closest first, today.

CompanyProfit margin
SSIISS Innovations International−23.7%
EMBCEmbecta8.6%
TCMDTactile Systems Technology7.1%
MDXGMimedx1.8%
MOVMovado6.0%
INFUInfuSystem6.0%
UTMDUtah Medical Products29.0%
PDEXPro DEX17.6%
IRMDIradimed26.7%
STAAStaar Surgical1.1%
BVSBioventus9.4%
Peer median7.8%

Where SS Innovations International ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on SS Innovations International

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.